Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.

Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ; Evolut Low Risk Trial Investigators.

N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16.

PMID:
30883053
2.

5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients.

Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, Kleiman NS, Chetcuti S, Hermiller JB Jr, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte JV, Mumtaz M, Oh JK, Huang J, Adams DH; CoreValve U.S. Pivotal High Risk Trial Clinical Investigators.

J Am Coll Cardiol. 2018 Dec 4;72(22):2687-2696. doi: 10.1016/j.jacc.2018.08.2146. Epub 2018 Sep 21.

PMID:
30249462
3.

Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap.

Forrest JK, Mangi AA, Popma JJ, Khabbaz K, Reardon MJ, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL 3rd, Brown J, Kipperman R, Saul S, Qiao H, Oh JK, Williams MR.

JACC Cardiovasc Interv. 2018 Jan 22;11(2):160-168. doi: 10.1016/j.jcin.2017.10.014.

4.

Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement.

Deeb GM, Chetcuti SJ, Yakubov SJ, Patel HJ, Grossman PM, Kleiman NS, Heiser J, Merhi W, Zorn GL 3rd, Tadros PN, Petrossian G, Robinson N, Mumtaz M, Gleason TG, Huang J, Conte JV, Popma JJ, Reardon MJ.

Ann Thorac Surg. 2018 Apr;105(4):1129-1136. doi: 10.1016/j.athoracsur.2017.08.059. Epub 2018 Jan 5.

PMID:
29307456
5.

Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.

Conte JV, Hermiller J Jr, Resar JR, Deeb GM, Gleason TG, Adams DH, Popma JJ, Yakubov SJ, Watson D, Guo J, Zorn GL 3rd, Reardon MJ.

Semin Thorac Cardiovasc Surg. 2017 Autumn;29(3):321-330. doi: 10.1053/j.semtcvs.2017.06.001. Epub 2017 Jun 19.

PMID:
29195573
6.

Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral.

Gleason TG, Schindler JT, Hagberg RC, Deeb GM, Adams DH, Conte JV, Zorn GL 3rd, Hughes GC, Guo J, Popma JJ, Reardon MJ.

Ann Thorac Surg. 2018 Feb;105(2):477-483. doi: 10.1016/j.athoracsur.2017.07.017. Epub 2017 Nov 1.

PMID:
29100645
7.

Safety and Feasibility of Rotational Atherectomy in Elderly Patients With Severe Aortic Stenosis.

Lippmann M, Patel J, Kvapil J, Westover D, Pierpoline M, Tadros P, Wiley M, Zorn G 3rd, Muehlebach G, Mehta A, Hockstad E, Earnest M, Gupta K.

J Invasive Cardiol. 2017 Aug;29(8):271-275.

8.

Causes of death from the randomized CoreValve US Pivotal High-Risk Trial.

Gaudiani V, Deeb GM, Popma JJ, Adams DH, Gleason TG, Conte JV, Zorn GL 3rd, Hermiller JB Jr, Chetcuti S, Mumtaz M, Yakubov SJ, Kleiman NS, Huang J, Reardon MJ.

J Thorac Cardiovasc Surg. 2017 Jun;153(6):1293-1301.e1. doi: 10.1016/j.jtcvs.2016.11.069. Epub 2017 Feb 4.

9.

Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less.

Reardon MJ, Kleiman NS, Adams DH, Yakubov SJ, Coselli JS, Deeb GM, O'Hair D, Gleason TG, Lee JS, Hermiller JB Jr, Chetcuti S, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Huang J, Popma JJ.

JAMA Cardiol. 2016 Nov 1;1(8):945-949. doi: 10.1001/jamacardio.2016.2257.

PMID:
27541162
10.

Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.

Little SH, Oh JK, Gillam L, Sengupta PP, Orsinelli DA, Cavalcante JL, Chang JD, Adams DH, Zorn GL 3rd, Pollak AW, Abdelmoneim SS, Reardon MJ, Qiao H, Popma JJ.

Circ Cardiovasc Interv. 2016 Jun;9(6). pii: e003426. doi: 10.1161/CIRCINTERVENTIONS.115.003426.

PMID:
27313280
11.

Prosthesis-Patient Mismatch: Another Reason for TAVR?

Oh JK, Zorn GL 3rd.

JACC Cardiovasc Imaging. 2016 Aug;9(8):934-6. doi: 10.1016/j.jcmg.2015.12.016. Epub 2016 May 25. No abstract available.

12.

3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.

Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, Kleiman NS, Coselli JS, Gleason TG, Lee JS, Hermiller JB Jr, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte J, Resar J, Aharonian V, Pfeffer T, Oh JK, Qiao H, Adams DH, Popma JJ; CoreValve US Clinical Investigators.

J Am Coll Cardiol. 2016 Jun 7;67(22):2565-74. doi: 10.1016/j.jacc.2016.03.506. Epub 2016 Apr 3.

13.

Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction.

Fellner B, Rohla M, Jarai R, Smetana P, Freynhofer MK, Egger F, Zorn G, Weiss TW, Huber K, Geppert A.

Eur Heart J Acute Cardiovasc Care. 2017 Jun;6(4):348-358. doi: 10.1177/2048872616637036. Epub 2016 Mar 2.

PMID:
26936869
14.

Direct Characterization of Polymer Encapsulated CdSe/CdS/ZnS Quantum Dots.

Zorn G, Dave SR, Weidner T, Gao X, Castner DG.

Surf Sci. 2016 Jun;648:339-344.

15.

A study of molecular adsorption of a cationic surfactant on complex surfaces with atomic force microscopy.

Sokolov I, Zorn G, Nichols JM.

Analyst. 2016 Feb 7;141(3):1017-26. doi: 10.1039/c5an01941a. Epub 2016 Jan 5.

PMID:
26730682
16.

Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis.

Zorn GL 3rd, Little SH, Tadros P, Deeb GM, Gleason TG, Heiser J, Kleiman NS, Oh JK, Popma JJ, Adams D, Huang J, Reardon MJ.

J Thorac Cardiovasc Surg. 2016 Apr;151(4):1014-22, 1023.e1-3. doi: 10.1016/j.jtcvs.2015.10.070. Epub 2015 Oct 28.

17.

G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.

Katsaros KM, Speidl WS, Demyanets S, Kastl SP, Krychtiuk KA, Wonnerth A, Zorn G, Tentzeris I, Farhan S, Maurer G, Wojta J, Huber K.

PLoS One. 2015 Nov 10;10(11):e0142532. doi: 10.1371/journal.pone.0142532. eCollection 2015.

18.

Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting.

Conte JV, Gleason TG, Resar JR, Adams DH, Deeb GM, Popma JJ, Hughes GC, Zorn GL, Reardon MJ.

Ann Thorac Surg. 2016 Jan;101(1):72-9; discussion 79. doi: 10.1016/j.athoracsur.2015.06.067. Epub 2015 Oct 1.

PMID:
26433523
19.

Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.

Arnold SV, Reynolds MR, Wang K, Magnuson EA, Baron SJ, Chinnakondepalli KM, Reardon MJ, Tadros PN, Zorn GL, Maini B, Mumtaz MA, Brown JM, Kipperman RM, Adams DH, Popma JJ, Cohen DJ; CoreValve US Pivotal Trial Investigators.

JACC Cardiovasc Interv. 2015 Aug 17;8(9):1207-1217. doi: 10.1016/j.jcin.2015.04.018.

20.

2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.

Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Lee JS, Hermiller JB Jr, Chetcuti S, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Qiao H, Popma JJ.

J Am Coll Cardiol. 2015 Jul 14;66(2):113-21. doi: 10.1016/j.jacc.2015.05.017. Epub 2015 Jun 5.

21.

Analysis of the surface density and reactivity of perfluorophenylazide and the impact on ligand immobilization.

Zorn G, Castner DG, Tyagi A, Wang X, Wang H, Yan M.

J Vac Sci Technol A. 2015 Mar;33(2):021407. Epub 2015 Feb 12.

22.

Grafting titanium nitride surfaces with sodium styrene sulfonate thin films.

Zorn G, Migonney V, Castner DG.

Biointerphases. 2014 Sep;9(3):031001. doi: 10.1116/1.4878215.

23.

Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery.

Reardon MJ, Adams DH, Coselli JS, Deeb GM, Kleiman NS, Chetcuti S, Yakubov SJ, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Khabbaz K, Tadros P, Zorn GL 3rd, Merhi W, Heiser J, Petrossian G, Robinson N, Maini B, Mumtaz M, Lee JS, Gleason TG, Resar J, Conte J, Watson D, Chenoweth S, Popma JJ; CoreValve US Clinical Investigators.

J Thorac Cardiovasc Surg. 2014 Dec;148(6):2869-76.e1-7. doi: 10.1016/j.jtcvs.2014.07.020. Epub 2014 Jul 30.

24.

Photo Quiz. Recurrent breast abscess in a 33-year-old woman.

Crum-Cianflone NF, Ballon-Landa G, Zorn G.

Clin Infect Dis. 2014 Aug 1;59(3):410; 454-5. doi: 10.1093/cid/ciu378. No abstract available.

PMID:
25023476
25.

Transcatheter aortic-valve replacement with a self-expanding prosthesis.

Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators.

N Engl J Med. 2014 May 8;370(19):1790-8. doi: 10.1056/NEJMoa1400590. Epub 2014 Mar 29.

26.

X-Ray Photoelectron Spectroscopy Investigation of the Nitrogen Species in Photoactive Perfluorophenylazide-Modified Surfaces.

Zorn G, Liu LH, Arnadóttir L, Wang H, Gamble LJ, Castner DG, Yan M.

J Phys Chem C Nanomater Interfaces. 2014 Jan 9;118(1):376-383.

27.

Predictive power of the fractalkine receptor CX3CR1 on CD4 T cells in patients with chronic heart failure.

Koller L, Blum S, Korpak M, Richter B, Goliasch G, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A.

Int J Cardiol. 2014 Jan 15;171(1):96-7. doi: 10.1016/j.ijcard.2013.11.082. Epub 2013 Dec 4. No abstract available.

PMID:
24342397
28.

Atrial fibrillation following open heart surgery: long-term incidence and prognosis.

Pillarisetti J, Patel A, Bommana S, Guda R, Falbe J, Zorn GT, Muehlebach G, Vacek J, Sue Min Lai, Lakkireddy D.

J Interv Card Electrophysiol. 2014 Jan;39(1):69-75. doi: 10.1007/s10840-013-9830-6. Epub 2013 Nov 29.

PMID:
24293173
29.

An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents.

Katsaros KM, Kastl SP, Krychtiuk KA, Hutter R, Zorn G, Maurer G, Huber K, Wojta J, Christ G, Speidl WS.

EuroIntervention. 2014 Jun;10(2):224-30. doi: 10.4244/EIJV10I2A36.

30.

CD4+ CD28(null) cells are an independent predictor of mortality in patients with heart failure.

Koller L, Richter B, Goliasch G, Blum S, Korpak M, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A.

Atherosclerosis. 2013 Oct;230(2):414-6. doi: 10.1016/j.atherosclerosis.2013.08.008. Epub 2013 Aug 19.

PMID:
24075776
31.

Discovery of the surface polarity gradient on iridescent Morpho butterfly scales reveals a mechanism of their selective vapor response.

Potyrailo RA, Starkey TA, Vukusic P, Ghiradella H, Vasudev M, Bunning T, Naik RR, Tang Z, Larsen M, Deng T, Zhong S, Palacios M, Grande JC, Zorn G, Goddard G, Zalubovsky S.

Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15567-72. doi: 10.1073/pnas.1311196110. Epub 2013 Sep 9.

32.

A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure.

Richter B, Koller L, Hohensinner PJ, Zorn G, Brekalo M, Berger R, Mörtl D, Maurer G, Pacher R, Huber K, Wojta J, Hülsmann M, Niessner A.

Int J Cardiol. 2013 Sep 30;168(2):1251-7. doi: 10.1016/j.ijcard.2012.11.052. Epub 2012 Dec 4.

PMID:
23218577
33.

Fractalkine is an independent predictor of mortality in patients with advanced heart failure.

Richter B, Koller L, Hohensinner PJ, Rychli K, Zorn G, Goliasch G, Berger R, Mörtl D, Maurer G, Huber K, Pacher R, Wojta J, Hülsmann M, Niessner A.

Thromb Haemost. 2012 Dec;108(6):1220-7. doi: 10.1160/TH12-03-0195. Epub 2012 Sep 26.

PMID:
23014777
34.

Role of hybrid endovascular suite in improving outcomes of surgical ligation of coronary artery fistula.

Steffen K, Zorn GT 3rd, Tadros P, Gupta K.

J Invasive Cardiol. 2012 Jan;24(1):E10-2.

35.

Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation.

Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, Bergler-Klein J, Binder T, Wojta J, Gössinger HD.

Clin Res Cardiol. 2012 Mar;101(3):217-25. doi: 10.1007/s00392-011-0383-3. Epub 2011 Nov 19.

PMID:
22102100
36.

Characterization of poly(sodium styrene sulfonate) thin films grafted from functionalized titanium surfaces.

Zorn G, Baio JE, Weidner T, Migonney V, Castner DG.

Langmuir. 2011 Nov 1;27(21):13104-12. doi: 10.1021/la201918y. Epub 2011 Sep 28.

37.

The prognostic impact of soluble apoptosis-stimulating fragment on mortality in patients with carotid atherosclerosis.

Hoke M, Schillinger M, Zorn G, Wonnerth A, Amighi J, Mlekusch W, Speidl W, Maurer G, Koppensteiner R, Minar E, Wojta J, Niessner A.

Stroke. 2011 Sep;42(9):2465-70. doi: 10.1161/STROKEAHA.110.611301. Epub 2011 Jul 14.

PMID:
21757675
38.

Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.

Rychli K, Richter B, Hohensinner PJ, Kariem Mahdy A, Neuhold S, Zorn G, Berger R, Mörtl D, Huber K, Pacher R, Wojta J, Niessner A, Hülsmann M.

Heart. 2011 Jul;97(14):1158-63. doi: 10.1136/hrt.2010.220228. Epub 2011 May 14.

PMID:
21572126
39.

Preoperative Statin use is not Associated with a Reduced Risk of Atrial Fibrillation After Cardiac Surgery.

Barnes BJ, Solomon S, Howard PA, Lakkireddy D, Kramer JB, Muehlebach GF, Daon E, Zorn GLT, Vacek JL.

J Atr Fibrillation. 2011 May 4;4(1):325. doi: 10.4022/jafib.325. eCollection 2011 May-Jun.

40.

High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.

Katsaros KM, Wiesbauer F, Speidl WS, Kastl SP, Huber K, Zorn G, Niessner A, Glogar D, Maurer G, Wojta J.

Thromb Haemost. 2011 May;105(5):883-91. doi: 10.1160/TH10-09-0566. Epub 2011 Feb 28.

PMID:
21359408
41.

Method for determining the elemental composition and distribution in semiconductor core-shell quantum dots.

Zorn G, Dave SR, Gao X, Castner DG.

Anal Chem. 2011 Feb 1;83(3):866-73. doi: 10.1021/ac102516n. Epub 2011 Jan 12.

42.

Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure.

Richter B, Rychli K, Hohensinner PJ, Berger R, Mörtl D, Neuhold S, Zorn G, Huber K, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A.

Atherosclerosis. 2010 Dec;213(2):545-8. doi: 10.1016/j.atherosclerosis.2010.08.061. Epub 2010 Aug 19.

PMID:
20843516
43.

Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome.

Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, Wolf F, Bergler-Klein J, Loewe C, Bieglmayer C, Binder T, Wojta J, Gössinger HD.

Int J Cardiol. 2011 Oct 20;152(2):231-6. doi: 10.1016/j.ijcard.2010.07.021. Epub 2010 Aug 6.

PMID:
20692054
44.

A simple and scalable route to wafer-size patterned graphene.

Liu LH, Zorn G, Castner DG, Solanki R, Lerner MM, Yan M.

J Mater Chem. 2010 Jun 28;20(24):5041-5046.

45.

Prognostic value of pigment epithelium-derived factor in patients with advanced heart failure.

Rychli K, Niessner A, Hohensinner PJ, Mahdy Ali K, Kaun C, Neuhold S, Zorn G, Richter B, Hülsmann M, Berger R, Mörtl D, Huber K, Maurer G, Pacher R, Wojta J.

Chest. 2010 Sep;138(3):656-64. doi: 10.1378/chest.09-2739. Epub 2010 Apr 30.

PMID:
20435653
46.

Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.

Katsaros KM, Kastl SP, Zorn G, Maurer G, Wojta J, Huber K, Christ G, Speidl WS.

JACC Cardiovasc Interv. 2010 Jan;3(1):90-7. doi: 10.1016/j.jcin.2009.10.023.

47.

Macrophage-modulating cytokines predict adverse outcome in heart failure.

Hohensinner PJ, Rychli K, Zorn G, Hülsmann M, Berger R, Mörtl D, Richter B, Huber K, Wojta J, Pacher R, Niessner A.

Thromb Haemost. 2010 Feb;103(2):435-41. doi: 10.1160/TH09-06-0399. Epub 2010 Jan 13.

PMID:
20076846
48.

Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a.

Speidl WS, Katsaros KM, Kastl SP, Zorn G, Huber K, Maurer G, Wojta J, Christ G.

Atherosclerosis. 2010 Jan;208(1):285-9. doi: 10.1016/j.atherosclerosis.2009.07.030. Epub 2009 Jul 23.

PMID:
19683238
49.

Non-conventional markers of atherosclerosis before and after gastric banding surgery.

Hanusch-Enserer U, Zorn G, Wojta J, Kopp CW, Prager R, Koenig W, Schillinger M, Roden M, Huber K.

Eur Heart J. 2009 Jun;30(12):1516-24. doi: 10.1093/eurheartj/ehp108. Epub 2009 Apr 20.

PMID:
19380349
50.

Prognostic value of apoptosis markers in advanced heart failure patients.

Niessner A, Hohensinner PJ, Rychli K, Neuhold S, Zorn G, Richter B, Hülsmann M, Berger R, Mörtl D, Huber K, Wojta J, Pacher R.

Eur Heart J. 2009 Apr;30(7):789-96. doi: 10.1093/eurheartj/ehp004. Epub 2009 Feb 4.

PMID:
19196721

Supplemental Content

Support Center